International position paper on febuxostat.
This position paper aims to clarify the presumed place of febuxostat in the management of gout patients. Since this novel xanthine oxidase inhibitor is now available, an international group of gout experts decided to formulate an international consensus statement. This statement presents the place for this new xanthine oxidase inhibitor in the treatment of gout which may contribute to optimize treatment of gout patients in Europe and worldwide.
Jansen
Tim L
TL
Department of Rheumatology, Medisch Centrum Leeuwarden, Leeuwarden, The Netherlands. t.jansen@znb.nl
Richette
Pascal
P
Perez-Ruiz
Fernando
F
Tausche
Anne-Kathrin
AK
Guerne
Philip-André
PA
Punzi
Leonardo
L
Leeb
Burkhard
B
Barskova
Victoria
V
Uhlig
Till
T
Pimentão
José
J
Zimmermann-Górska
Irena
I
Pascual
Elisio
E
Bardin
Thomas
T
Doherty
Michael
M
D000069465:Febuxostat; D006073:Gout / Q000188:drug therapy*; D006074:Gout Suppressants / Q000627:therapeutic use*; D006801:Humans; D007391:International Cooperation; D013844:Thiazoles / Q000627:therapeutic use*; D016896:Treatment Outcome; D014969:Xanthine Oxidase / Q000037:antagonists & inhibitors
D006074:Gout Suppressants; D013844:Thiazoles; D000069465:Febuxostat; D014969:Xanthine Oxidase
N Engl J Med. 2005 Dec 8;353(23):2450-61
16339094
Ann Rheum Dis. 2006 Oct;65(10):1312-24
16707532
Ann Rheum Dis. 2009 Jun;68(6):892-7
18633127
Ann Rheum Dis. 2009 Jan;68(1):51-6
18250112
Ann Rheum Dis. 2007 Oct;66(10):1269-70
17881662
Rheumatology (Oxford). 2009 May;48 Suppl 2:ii9-ii14
19447780
Rheumatology (Oxford). 2009 Feb;48(2):188-94
19141576
Arthritis Rheum. 2008 Nov 15;59(11):1540-8
18975369
Arthritis Rheum. 2005 Mar;52(3):916-23
15751090
Curr Opin Rheumatol. 2005 May;17(3):319-24
15838244
Rheumatology (Oxford). 2007 Aug;46(8):1372-4
17522099
Ann Rheum Dis. 2006 Oct;65(10):1301-11
16707533